Join Dr. Art Hsing-Mao Chu, CEO of T-E Meds, at World ADC San Diego 2024 on Nov 4th to hear more about our breakthrough technology. Join Dr. Kun-Po Li, the Director of Business Development of T-E Meds, to present our novel ADC technology (Poster Number: 84). This breakthrough technology features dual-payloads and a high drug-to-antibody … Continue reading Join our presentation at the World ADC San Diego 2024